Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Tables)

v3.20.2
EARNINGS PER SHARE (Tables)
9 Months Ended
Aug. 31, 2020
Earnings Per Share [Abstract]  
Schedule of anti-dilutive shares

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

  

    For the Three Months Ended
August 31,
    For the Nine Months Ended
August 31,
    2020     2019     2020     2019
Series A Preferred Stock     46,366,490             46,366,490      
Warrants     7,748,174       45,787,219       7,748,174       45,787,219
Stock Options     7,136,667       2,911,667       7,136,667       2,911,667
Total     61,251,331       48,698,886       61,251,331       48,698,886